Friday, 18 Oct 2019

Gout/Crystal

Date Typesort descending Title Save
16 May 2019 Social Medicare analysis shows Gout patients are twice as likely to have chronic pain (HR 2.02; 95% CI 1.98-2.05) and use of allopurinol or febuxostat was associated with a lower risk of chronic pain (HR 0.72-0.79) https://t.co/xW5rVPyC69
26 Apr 2016 Social Astra-Zeneca sells the rights to sell gout drug Zurampic (lesinurad) to Ironwood pharmaceutical for $265 million. https://t.co/GXht3lje3s
10 Jun 2015 Social Efficacy of Anakinra in Crystal synovitis. Complete improvement is seen in 3-5 days http://t.co/oTmnycx9m1
07 Nov 2017 Social RT @KDAO2011: Prior allopurinol use may reduce risk for NSAID induce acute kidney injury in gout pts #141 #ACR17 @rheumnow https://t.co/HTA…
07 Aug 2018 Social 10 yr study of ~13k US VA gout pts who did/didnt increase allopurinol shows dose escalation seldom achieved target SUA <6.0, but was associated with increased mortality (HR 1.08; 95%CI 1.01–1.17). Escalation more a marker of severity, not T2T https://t.co/NxzhnUfU2M
11 Jun 2016 Social 1,280 gout compared to 1,231 OA pts; gout had more CVD risk factors, hypertension, ^lipids, CKD but not more MI. https://t.co/zP2SK3tfeM
01 Dec 2016 Social Takeda 2 yr study of 314 early #gout pts showed less acute flares w/ Uloric vs PBO (29% v 41%), but not in 1st 6mos. https://t.co/oTCYXyEX6o
04 Mar 2018 Social RheumNow Wk in Review is up. Cool stuff on FDG PET in Lg Vessel vasculitis, gout Rx, nutraceuticals in OA. Listen here ht tps://buff.ly/2FhsZZH or watch it on website https://t.co/OZ1nGhCrSP
17 Aug 2015 Social Salivery uric acid levels measureable in gout - more proof that gout is a systemic uric acid deposition disease http://t.co/cA03VMuG39
07 Aug 2019 Social Prospective study of 83 gout patients; 77 on urate lowering Rx, 6 discontinued Rx. The D/C group had no change in MSU deposits or SUA levels, In the ULT group MSU burden significantly decreased (MSU volume: p=0.007) and sUA dropped from 7.2 to 5,8 mg/dl. https://t.co/YfXjTKz1va
15 Mar 2017 Social Xrays & DECT in 92 gout pts, tophi and urate assoc w/ 80% of all erosions. Urate, tophus volume predict erosions https://t.co/JlDle82bUx
22 Sep 2016 Social #Gout & anti-HTN meds: diuretics, ꞵ-blockers, α-1 blockers signif increase uric acid levels. No effect w/ CCB, ACEI https://t.co/LnUTfz3zab
16 May 2017 Social Drug induced hyperuricemia: Diuretics, EMB, PZA, ASA, CyA, fructose, nicotinic acid, Xylitol, lactate, cytotoxics https://t.co/CXdGxBJaMP
26 Oct 2015 Social 75 pts >50 yrs w knee effusions were studied:Ultrasound was more sensitive(60 v 40%) & specific (97 v 83%) than Xray https://t.co/dKr2BbZphN
27 Oct 2017 Social RheumNow Wk in Review is up! Cush on gout, CV risk, Biosimilars,FDA approvals.Vid or podcast https://t.co/UJHqRBPPGo https://t.co/MYf4CnCWOR
16 Mar 2016 Social In a 6 mos RCT, Febuxostat slows the decline in GFR in CKD stages 3/4 compared to placebo. https://t.co/Au1mli9jAG
09 May 2015 Social Review of Losartan shows its uricosuric, can lower Uric acid ~1.6 mg/dl & may be useful in HTN w/ hyperuricemia http://t.co/0zVqsvQIcO
06 Nov 2017 Social RT @Janetbirdope: #GAMECHANGERS If you have gout and typeII diabetes you have worse gout. More tophi and erosions. #acr17 @rheumnow #1118…
06 Jun 2019 Social The overall prevalence of gout among US adults is 3.9%, affecting 9.2 million people. Hyperuricaemia prevalence is 14.6% - affecting 32.5 million in the US. Data from NHANES NHANES 2015–16 https://t.co/3g05GmUDUA
10 May 2016 Social Population (34K) based Taiwan study shows gout assoc w/ higher risk of depression; that is normalized w/ pred or ULT https://t.co/eRUJa4cLIr